Detalles de la búsqueda
1.
Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices.
J Natl Compr Canc Netw
; 13(11): 1383-93, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26553767
2.
Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.
Lancet Oncol
; 14(11): 1121-1128, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24007746
3.
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).
J Clin Oncol
; 42(12): 1344-1349, 2024 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38335467
4.
Phase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patients.
Breast Cancer Res Treat
; 142(2): 381-8, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24166282
5.
Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: results of a Phase II trial.
Invest New Drugs
; 31(5): 1330-8, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23761052
6.
Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial.
Lancet
; 377(9762): 321-31, 2011 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-21247627
7.
Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphoma.
Blood
; 115(3): 475-80, 2010 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-19965689
8.
A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemia.
Invest New Drugs
; 30(3): 1232-40, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21922186
9.
A phase II open-label trial of bortezomib in patients with multiple myeloma who have undergone an autologous peripheral blood stem cell transplant and failed to achieve a complete response.
Invest New Drugs
; 30(2): 714-22, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20938715
10.
Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer.
Breast Cancer Res Treat
; 126(1): 101-8, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21188632
11.
Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: results of a phase II, randomized, noncomparative study.
Invest New Drugs
; 29(1): 144-53, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19714296
12.
Outcomes After Accelerated Partial Breast Irradiation in Women With Triple Negative Subtype and Other "High Risk" Variables Categorized as Cautionary in The ASTRO Guidelines.
Front Oncol
; 11: 617439, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33777758
13.
Timing for Step-Down Therapy of Candidemia in Non-Neutropenic Patients: An International Multi-Center Study.
Mediterr J Hematol Infect Dis
; 13(1): e2021031, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34007419
14.
A prospective Phase III trial evaluating patient self-reported pain and cosmesis in accelerated partial breast irradiation utilizing 3-D versus intensity-modulated radiotherapy.
Cancer Med
; 10(20): 7089-7100, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34469056
15.
Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer.
Breast Cancer Res Treat
; 118(2): 361-7, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19459042
16.
Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients.
NPJ Breast Cancer
; 5: 36, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31667338
17.
Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer.
Clin Breast Cancer
; 8(2): 178-86, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18621615
18.
The effect of tamoxifen or exemestane on bone mineral density during the first 2 years of adjuvant treatment of postmenopausal women with early breast cancer.
Clin Breast Cancer
; 8(6): 527-32, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19073509
19.
Results of a phase II trial of cetuximab plus capecitabine/irinotecan as first-line therapy for patients with advanced and/or metastatic colorectal cancer.
Clin Colorectal Cancer
; 7(6): 390-7, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19036692
20.
Phase II trial of sunitinib for the therapy of progressive metastatic castration-refractory prostate cancer after previous docetaxel chemotherapy.
Clin Genitourin Cancer
; 6(2): 134-7, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18824440